Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133955) titled 'Study on the Efficacy and Safety of Anruikefon in Analgesia for Gynecological Day Surgery' on Oct. 9.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Guangdong Province Hospital for Women and Children Healthcare
Condition:
Intraoperative Pain Management in Gynecological Day Surgery (Induced Abortion, Hysteroscopy)
Intervention:
Sequential Dose Exploration Group:Use Up-and-Down sequential method to screen the optimal analgesic dose of ED95 for Anreikifen combined with 0.4 mg/kg Remifentanil for gynecological day surgery. Starting dose is 1µg/kg, dose gradient 0.1 µg/kg, d...